Correlates of treatment satisfaction and well‐being among patients with type II diabetes

Aim

To examine the impact of patient characteristics, anthropometric measurement and patient clinical variables on their appraisal of treatment satisfaction and well‐being.

Background

Treatment satisfaction and well‐being are instrumental in achieving diabetes care goals. Nursing practices and healthcare policies may inform interventions in these areas.

Introduction

The prevalence of diabetes is high in the Middle East. An understanding of relationships between clinical and socio‐demographic variables and well‐being and treatment satisfaction is needed to improve care and patient outcomes.

Methods

A total of 1002 patients completed tools measuring well‐being, treatment satisfaction and socio‐demographic characteristics. A series of bivariate and multivariate analysis were conducted to identify factors associated with well‐being and treatment satisfaction.

Results

Males reported better treatment satisfaction and well‐being than females. Older participants, those who were compliant to diet, with controlled diabetes, and no neuropathy reported higher treatment satisfaction scores and well‐being scores. Insulin therapy was associated with better treatment satisfaction.

Discussion

Females, participants who were not prescribed diabetic diets and those with complications were more likely to be negatively impacted by diabetes. Individuals with diabetes who were treated with insulin had higher treatment satisfaction than those who used oral hypoglycaemic agents.

Conclusion and implication for nursing and health policy

These findings are important in assisting nurses and other healthcare professionals in identifying patients with diabetes with low treatment satisfaction who may present a greater risk for poor well‐being. Additionally, they lend support to developing policies for frequent screenings and special therapeutic interventions that are needed to maximize patients’ treatment satisfaction and well‐being in the Middle East and elsewhere.     

感染科实施人性化护理的应用效果分析

目的：分析人性化护理在感染科患者中的应用效果。方法随机选取50例感染科患者实施人性化护理,作为试验组;抽取同期50例传染病患者实施常规护理,作为对照组。观察并比较人性化护理在传染病护理中的应用效果。结果试验组患者的抑郁和焦虑状态与对照组相比改善更为明显,而且患者对人性化护理的模式更适应并且非常满意。结论对传染病患者实施人性化护理不仅改善了患者的身体和心理状况,还能帮助患者建立对抗疾病的信心,护理工作也因此能够更顺利地进行。     

护理干预联合左卡尼丁在维持性血液透析患者中的应用效果

目的:探讨护理干预联合左卡尼丁在维持性血液透析患者中的应用效果。方法:2017年9月至2019年10月,将86例维持性血液透析患者作为研究目标,按照随机数表法分为对照组43例(常规护理);观察组43例(系统化护理)。对比两组的护理满意度、心理健康状态以及各项炎症指标。结果:两组患者护理满意度分别为74.42%、95.35%(P<0.05)。对照组、观察组患者心理健康状况评分差异显著(P<0.05)。对照组、观察组患者白细胞介素6、肿瘤坏死因子α、C反应蛋白水平差异显著(P<0.05)。结论:通过对维持性血液透析患者采用护理干预联合左卡尼丁治疗,能够有效改善其心理健康状态、恢复各项炎症指标,疗效显著,临床应用价值较高。     

住院药房药学服务满意度调查与分析

目的:为满足解放军总医院第五医学中心(以下简称“我院”)住院药房实际工作的需要,优化药学部药学服务质量,提高药学服务满意度。方法:采取随机抽样的方法,收集我院28个临床科室工作人员关于药学服务满意度的调查问卷。采用利克特量表,设置态度分值,通过Microsoft Excel软件对评分进行统计分析。结果:收集有效问卷226份,满意度平均得分>4.3分;病区对住院药房的药学服务基本满意,用药咨询评分最低,仅为(4.38±0.49)分,发药准确度[(4.44±0.89)分]和有效沟通[(4.84±0.39)分]方面有待提高。结论:我院各科室对住院药房的药学服务基本满意,问题主要体现在用药咨询和发药准确度等方面,整体药学服务质量还有一定的上升空间。     

肾移植受者手术决策参与满意度的调查研究

目的 了解肾移植受者手术决策参与满意度现状并分析其影响因素。 方法 2020年11月—2021年1月,采用便利抽样法选取成都市某三级甲等综合医院器官移植门诊随访的272例肾移植受者进行调查。采用肾移植受者一般资料调查表、决策期待量表、患者家属手术决策参与程度调查表、患者对医疗决策知情程度调查表、患者对医疗决策参与的满意度调查问卷,对肾移植受者进行调查。 结果 肾移植受者手术决策参与满意度总分为（78.84±11.47）分,其中,信息维度得分为（70.70±17.14）分,交流协商维度得分为（79.69±13.75）分,决策维度得分为（80.73±12.47）分,总满意度及信心维度得分为（84.25±12.67）分。年龄、家属参与手术决策的程度、医疗费用支付方式以及患者对于手术决策知情程度等对肾移植受者手术决策参与满意度有影响（均P<0.05）。多元线性回归分析显示,患者对于手术决策知情程度是肾移植受者手术决策参与满意度的独立影响因素（P<0.001）。 结论 肾移植受者手术决策参与满意度水平有待提高,对手术决策的知情程度是影响其参与满意度的主要因素。医护人员应结合肾移植受者年龄和家属参与程度,对其手术决策知情情况进行综合评估,制订个体化决策辅助干预措施。     

Sexual function,satisfaction with life and menopausal symptoms in middle-aged women

Purpose

To assess sexual function, satisfaction with life (SWL), and menopause-related symptoms among mid-aged Spanish women.

Materials and methods

Cross-sectional study of 260 women, aged 40–59, attending the public gynecology consultations completed the 14-item Changes in Sexual Functioning Questionnaire (CSFQ-14), the SWL Scale (SWLS), the Menopause Rating Scale (MRS), and a socio-demographic questionnaire.

Results

Median [inter quartile range] age was 47 [8.0] years, 87.7% had a stable partner, 27.0% were postmenopausal, and 53.9% had increased body mass index (BMI). The prevalence of sexual dysfunction was 46.5% (CSFQ-14 score ≤ 41). Postmenopausal status was associated with lower CSFQ-14 scores (worse sexual function) and severe menopausal symptoms whereas there were not significant differences in SWLS scores. CSFQ-14 scores correlated with SWLS (p < 0.04), and inversely correlated with menopausal symptoms (p < 0.02). Multiple linear regression analysis model predicted 26.6% of the total CSFQ-14 score variance, and higher scores (better sexual function) were correlated with better SWL, and inversely correlated to female age and worse menopausal symptoms. A second model predicted 38.4% of the SWLS score variance. The SWLS score correlated with the total CSFQ-14 score and BMI, and inversely correlated with economical problems, female tobacco use, lack of healthiness, menopausal symptoms, not having a partner, and partner's lack of healthiness.

Conclusions

Lower sexual function was related to low SWL, age and menopausal symptoms while low SWLS score was related with economical problems, smoking, menopausal symptoms, and partner factors.     

Patient-health care provider communication among patients with newly diagnosed prostate cancer: Findings from a population-based survey

Objective

To examine the multidimensional concept of patient-health care provider (HCP) communication, its effects on patient satisfaction with oncology care services, and related racial differences.

Methods

The current analysis draws from a population-based survey sample of 1011 African American and 1034 Caucasian American men with newly diagnosed prostate cancer. The variables of satisfaction with health care services, interpersonal treatment, contextual knowledge of the patient, and prostate cancer communication were analyzed using multiple-group structural equation modeling.

Results

Regardless of race, patient-HCP communication was related positively to interpersonal treatment by the HCP, HCP's contextual knowledge of the patient, and prostate cancer communication. More positive patient-HCP communication was related to more satisfaction with health care services. Racial differences were significant in the relationships between patient-HCP communication and prostate cancer communication.

Conclusion

Content and interpersonal relationships are important aspects of patient-HCP communication and affect patient satisfaction with oncologic care for prostate cancer.

Practice implications

HCPs need to integrate the transfer of information with emotional support and interpersonal connection when they communicate with men with newly diagnosed prostate cancer.     

药物治疗满意度量表第二版中文版测评高血压患者的效度和信度

目的:评价药物治疗满意度量表第二版(TSQM-Ⅱ)中文版在高血压患者中的效度和信度。方法:使用TSQM-Ⅱ、Morisky服药依从性量表(MMAS-8)对445例在某三级甲等综合医院及某社区卫生服务中心的高血压患者施测。采用量表内容效度指数(S-CVI)和条目内容效度指数(I-CVI)评价TSQM-Ⅱ的内容效度,采用探索性因子分析和验证性因子分析检验其结构效度,采用MMAS-8检验实证效度,用内部一致性信度、重测信度检验信度。结果:TSQM-Ⅱ的S-CVI为0.95,I-CVI在0.83~1.00之间;探索性因子分析共抽取3个公因子,累积方差解释率为88.50%;验证性因子分析各项拟合指标良好(χ^2/df=2.36,GFI=0.90,RMSEA=0.08,RMR=0.03);MMAS-8得分与TSQM-Ⅱ各。维度及总量表得分均呈正相关(r=0.38~0.41,均P<0.01)。量表Cronbachα系数为0.92,折半系数为0.83,重测信度为0.87。结论:药物治疗满意度量表第二版(TSQM-Ⅱ)中文版在高血压患者中具有良好效度和信度,适用于评价高血压患者的药物治疗满意度水平,但其效标效度尚须进一步研究。